4.5 Article

PSA density is complementary to prostate MP-MRI PI-RADS scoring system for risk stratification of clinically significant prostate cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography The IP1-PROSTAGRAM Study

David Eldred-Evans et al.

Summary: In this cohort study, MRI with a score of 4 or 5 as a positive test result detected more clinically significant prostate cancer cases compared to PSA testing alone at 3 ng/mL or higher, without increasing unnecessary biopsies or overdiagnosing clinically insignificant cancer. Ultrasonography did not show superior performance to PSA testing alone.

JAMA ONCOLOGY (2021)

Article Medicine, General & Internal

Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer

Thomas Callender et al.

Summary: The study evaluated the benefits of using MRI in prostate cancer screening, showing that MRI-first screening can reduce overdiagnosis and the number of biopsies, while improving patient survival rates. Conducting MRI screening based on age and risk-stratified strategies is the most cost-effective approach.

JAMA NETWORK OPEN (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Multiparametric MRI-Based Radiomics for Prostate Cancer Screening With PSA in 4-10 ng/mL to Reduce Unnecessary Biopsies

Yafei Qi et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2020)

Article Urology & Nephrology

Rethinking prostate cancer screening: could MRI be an alternative screening test?

David Eldred-Evans et al.

NATURE REVIEWS UROLOGY (2020)

Article Oncology

Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer

Erica Stevens et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)

Article Oncology

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Tobias Nordstrom et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2018)

Meeting Abstract Urology & Nephrology

ROLE OF MPMRI PSA DENSITY AND PIRADS SCORE IN PREDICTING UPSTAGING IN MEN ON ACTIVE SURVEILLANCE

Michelle Van Kuiken et al.

JOURNAL OF UROLOGY (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Assessment of PI-RADS v2 for the Detection of Prostate Cancer

Moritz Kasel-Seibert et al.

EUROPEAN JOURNAL OF RADIOLOGY (2016)

Article Medicine, General & Internal

Comparison of MR/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

M. Minhaj Siddiqui et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Oncology

Multiparameric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study

Valeria Panebianco et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)

Article Urology & Nephrology

Optimizing Patient Population for MP-MRI and Fusion Biopsy for Prostate Cancer Detection

Thomas P. Frye et al.

CURRENT UROLOGY REPORTS (2015)

Review Urology & Nephrology

Systematic Review of Complications of Prostate Biopsy

Stacy Loeb et al.

EUROPEAN UROLOGY (2013)